Physician profile

Utpal Pandya

Cardiovascular Disease · Atlanta, GA

NPI 1649254848

$220,717.87

in general payments reported to CMS, 2019-2025

4 companies · $220K in 2025

The $220K reported for 2025 was more than what 99% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Acquisitions$220,391.70

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Edwards Lifesciences Corporation $220,391.70 2025
Shockwave Medical, INC $182.68 2022
Medtronic Vascular, INC. $143.49 2019-2020

1 company reported research payments only; those appear in the research section below.

Research and ownership

$406,703.92 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Utpal Pandya

$220,717.87

in general payments reported 2019-2025

Years
2019-2025
Top company
Edwards Lifesciences Corporation
Context
The $220K reported for 2025 was more than what 99% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/347045/utpal-pandya

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.